Q4 Results: Metropolis Health Earnings Miss Estimates; Dalmia Bharat Sugar Profit More Than Doubles

Aurionpro Solutions Q4 FY25 Results Highlights (Consolidated, YoY)

• Revenue up 32% at Rs 327 crore versus Rs 247 crore

• Ebitda up 25.4% at Rs 66 crore versus Rs 52.6 crore

• Margin at 20.2% versus 21.3%

• Net Profit up 31% at Rs 50.3 crore versus Rs 38.5 crore

Chemplast Sanmar Q4 FY25 Results Highlights (Consolidated, YoY)

• Revenue up 9.5% at Rs 1,150.8 crore versus Rs 1,050.7 crore

• EBITDA up 75% at Rs 36.7 crore versus Rs 21 crore

• Margin at 3.2% versus 2%

• Net Loss of Rs 54.17 crore versus loss of Rs 31.13 crore

Dalmia Bharat Sugar Q4 FY25 Results Highlights (YoY)

• Revenue up 35.7% at Rs 1,017.8 crore versus Rs 750 crore

• Ebitda up 63.8% at Rs 194.4 crore versus Rs 118.7 crore

• Margin at 19.1% versus 15.8%

• Net profit up at Rs 206 crore versus Rs 91 crore

Metropolis Healthcare Q4 FY25 Results Highlights (Consolidated, YoY)

• Revenue up 4.3% at Rs 345.3 crore versus Rs 331 crore (Bloomberg estimate: Rs 353 crore)

• Ebitda down 22% at Rs 62.3 crore versus Rs 80 crore (Bloomberg estimate: Rs 83.4 crore)

• Margin at 18% versus 24.2% (Bloomberg estimate: 23.6%)

• Net profit down 20% at Rs 29.1 crore versus Rs 36.4 crore (Bloomberg estimate: Rs 39 crore)

VST Tillers Q4 FY25 Results Highlights (Consolidated, YoY)

• Revenue up 10.2% at Rs 301 crore versus Rs 273 crore

• Ebitda up 1.4% at Rs 40.4 crore versus Rs 40 crore

• Margin at 13.4% versus 14.6%

• Net profit down 29.7% at Rs 24.4 crore versus Rs 34.8 crore